Enzolytics Inc (ENZC)

[docsetc]

I said NASDAQ, because a lot of emerging biotechs starting in the pennies, if they have the goods, have wound up on Nasdaq settling in at about $4.00 - $22.00 pps.

NVAX and DVAX started this way, I was there when they first hit the OTC pages.